Grounded in peer-reviewed science
Digitized spiral analysis is a validated motor assessment method with 35+ years of published research across 300+ peer-reviewed studies. A scoping review of 120 studies in Movement Disorders Clinical Practice documents strong test-retest reliability and substantial discriminative performance across PD and ET populations. NeuroQuantix standardizes this evidence base into a regulatory-grade digital endpoint platform.
Featured Publication
Movement Disorders Clinical Practice · 2025; 12(11): 1742–1755
Clinical Applications and Measurement Properties of the Digitized Archimedes Spiral Drawing Test: A Scoping Review
Wang S, Schwirtlich T, McLaughlin D, Beestrum M, Heinemann AW
A comprehensive scoping review of 120 studies (screened from 1,407 citations across six databases) evaluating the digitized Archimedes spiral drawing test as a clinical outcome measurement instrument. The review maps the field's evidence on reliability, validity, and responsiveness across PD, ET, and emerging applications. It identifies the standardization gaps that NeuroQuantix is designed to address.
Strong Reliability
Strong test-retest reliability across 14 studies in PD and ET populations. Digital measures showed lower variability than expert visual ratings.
Validated Against Gold Standards
Strong correlations with accelerometry, FTM tremor ratings, and traditional clinical tremor scales across 45 validity studies.
Sensitive to Interventions
Demonstrated responsiveness to L-dopa, ethanol, MR-guided focused ultrasound thalamotomy, and deep brain stimulation across 6 studies.
Gap: Standardization
Significant variability in devices, drawing tasks, and analysis methods across studies. The review calls for harmonized protocols — exactly what NeuroQuantix provides.
Gap: Beyond PD & ET
Evidence for reliability and responsiveness outside PD/ET remains limited. NeuroQuantix addresses this with 23-condition differential profiles.
Gap: Reporting Standards
63.3% of studies did not specify speed/accuracy instructions. The review calls for standardized reporting — a core design principle of the NeuroQuantix protocol.
Evidence Foundation
NeuroQuantix synthesizes 300+ peer-reviewed studies into 397 metrics across 12 functional domains, with 82 diagnostic rules covering 23 neurological conditions. Each metric traces to published literature spanning the digitized spiral analysis era from the early 1990s to the present.
Canonical literature references mapped to metrics with structured evidence provenance
Across 12 functional domains, each with documented clinical relevance and literature backing
Evidence-graded (A through D) with full citation provenance and documented thresholds
Spanning the digitized tablet era from foundational quantitative methods (early 1990s) through current digital biomarker validation
Key Published References
Haubenberger et al., 2011
Tremor velocity spectral peak reliability and sample size methodology for ET
Zham et al., 2017
CISP composite for PD detection and traditional scale correlation
Elble & Ellenbogen, 2017
TETRAS inter-rater reliability foundational study
Pullman et al., 2021
DBS on/off discrimination via RMSE and smoothness metrics
Sisti et al., 2017
Spiral analysis methodology and kinematic feature extraction
Wang, McLaughlin et al., 2025
Scoping review of 120 studies on digitized spiral analysis
Research shared with the Movement Disorder Society community and published in Wiley-indexed journals.
Prospective Validation Study
A prospective, multi-site, observational study designed to establish the full psychometric properties of the NeuroQuantix Spiral Analysis Platform as a Clinical Outcome Assessment for movement disorders.
Academic Sites
Primary Endpoints
Collaborate with us
We are actively seeking research partnerships to expand the evidence base for digital neuroscience assessment. Two ways to get involved:
Join the Validation Study
Our prospective, multi-site validation study across four academic centers is designed to establish the full psychometric properties of the NeuroQuantix platform. We welcome academic sites with movement disorder patient populations and established research infrastructure.
Discuss Site ParticipationUse NeuroQuantix in Your Research
Investigators running grant-funded or investigator-initiated studies can integrate NeuroQuantix or FaceWise as digital endpoints. We provide technical support, data export configuration, and co-authorship opportunities for collaborative research.
Explore Research UseFrequently Asked Questions
What is digitized spiral analysis?
Digitized spiral analysis is a quantitative motor assessment method where patients draw an Archimedes spiral on a digital tablet (iPad Pro or Wacom digitizer). The tablet captures pen position, pressure, and tilt at 240 samples per second. Software algorithms extract kinematic metrics including tremor frequency, amplitude, velocity, jerk, spatial accuracy, and motor smoothness. The method has 35+ years of published research across 300+ peer-reviewed studies, as documented in a scoping review of 120 studies in Movement Disorders Clinical Practice (Wang et al., 2025).
How reliable is digital spiral analysis?
Digital spiral analysis demonstrates strong test-retest reliability across 14 published test-retest studies in PD and ET populations. The velocity spectral peak metric is among the most reliable kinematic measures of tremor. Digital measures show lower variability than expert visual ratings, with strong correlations to accelerometry and traditional clinical tremor scales across 45 validity studies.
How does the measurement sensitivity of digital endpoints compare to traditional rating scales?
Continuous, high-frequency kinematic measurement provides substantially higher sensitivity than ordinal rating scales. The result is greater statistical power per subject, which enables powered studies with smaller cohorts and increases the probability of detecting real treatment effects. Digital endpoints are designed to complement traditional clinician-rated scales (which provide regulatory precedent and clinical interpretability), not replace them.
Interested in the evidence base?
Request a detailed technical brief, discuss the validation study design, or explore how NeuroQuantix can serve as an endpoint in your clinical program.